Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2012
04/19/2012WO2011163312A3 Improving efficacy of cancer therapy
04/19/2012WO2011163308A3 Compositions and methods for preventing and treating organ injury and/or dysfunction
04/19/2012WO2011159771A3 Compositions and methods for treating cancer
04/19/2012WO2011156518A3 Estrogen receptor modulators and uses thereof
04/19/2012WO2011153331A3 Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo
04/19/2012WO2011153192A3 Cytochrome p450 inhibitors and uses thereof
04/19/2012WO2011153157A3 Benzoquinolone inhibitors of vmat2
04/19/2012WO2011150418A3 Compositions and methods for treating pathologies
04/19/2012WO2011150229A3 Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity
04/19/2012WO2011150094A3 Tumor suppression compositions
04/19/2012WO2011133858A3 Compositions, methods of use, and methods of treatment
04/19/2012WO2011130692A3 Androgen induced oxidative stress inhibitors
04/19/2012WO2011129936A4 Compositions and methods for the prevention and treatment of cancer
04/19/2012WO2011127393A3 Variants of ancestral uricases and uses thereof
04/19/2012WO2011127202A3 Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting the growth and/or proliferation of myc-driven tumor cells
04/19/2012WO2011126864A3 Cancer treatment with recombinant vector
04/19/2012WO2011126821A3 Indolyl or indolinyl hydroxamate compounds
04/19/2012WO2011122916A3 Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of tip41 which is a trail sensitizer target gene
04/19/2012WO2011115810A3 Isoform-specific rnai based on codon redundancy/degeneracy
04/19/2012WO2011113030A3 Human cancer micro-rna expression profiles predictive of chemo-response
04/19/2012WO2011103586A9 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
04/19/2012WO2011077098A9 Inhibitors of akt activity
04/19/2012WO2011069074A3 Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1
04/19/2012WO2011036561A8 Process
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
04/19/2012US20120095108 Composition containing microbial zeaxanthin and preparation thereof
04/19/2012US20120095103 Compounds for treating proliferative disorders
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095092 Amide derivatives of benzene-sulfonanilide, pharmaceutical composition thereof and method for cancer treatment using the same
04/19/2012US20120095089 Schweinfurthins and uses thereof
04/19/2012US20120095086 Protein tyrosine phosphatase mutations in cancers
04/19/2012US20120095081 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/19/2012US20120095079 Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
04/19/2012US20120095078 Methods of diagnosis and treatment of melanoma
04/19/2012US20120095071 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
04/19/2012US20120095068 Imidazolidine-2,4-dione derivatives and use thereof as a medicament
04/19/2012US20120095066 Composition Comprising An Epothilone And Methods For Producing A Composition Comprising An Epothilone
04/19/2012US20120095065 Macrocyclic compounds and methods of treatment
04/19/2012US20120095057 Pyrazole compound
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095047 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors
04/19/2012US20120095045 Injectable anticancer composition for local administration containing hydroxychloroquine
04/19/2012US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
04/19/2012US20120095038 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095037 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120095032 Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
04/19/2012US20120095030 Methods and kits to predict therapeutic outcome of tyrosine kinase inhibitors
04/19/2012US20120095029 Ipp complex as marker for erlotinib treatment
04/19/2012US20120095027 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095026 Inhibitors of bruton's tyrosine kinase
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095024 Toluidine sulfonamides and their use
04/19/2012US20120095022 Derivatives of 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-ones, method for preparation thereof and therapeutic uses thereof
04/19/2012US20120095014 Aminopyrimidines useful as kinase inhibitors
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095011 Novel compounds
04/19/2012US20120095010 Tricyclic delta-opioid modulators
04/19/2012US20120095009 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095004 Sphingosine Kinase Inhibitors
04/19/2012US20120095000 Compounds for activating tgf-beta signaling
04/19/2012US20120094999 Egfr inhibitors and methods of treating disorders
04/19/2012US20120094998 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
04/19/2012US20120094997 Substituted hydroxamic acids and uses thereof
04/19/2012US20120094996 Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives
04/19/2012US20120094992 Poly (adp-ribose) polymerase (parp) inhibitors
04/19/2012US20120094991 1, 4-Benzoxazine Compounds and Derivatives Thereof as Therapeutic Drugs for the Treatment of Neurodegenerative Conditions
04/19/2012US20120094990 Phenylacetic acid compound
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094986 Anticancer deriviatives, preparation thereof, and therapeutic use thereof
04/19/2012US20120094982 1,4-benzodiazepinone compounds and their use in treating cancer
04/19/2012US20120094980 Pyridyl inhibitors of hedgehog signalling
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094976 New chemical compounds
04/19/2012US20120094975 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
04/19/2012US20120094974 Smoothened receptor modulators
04/19/2012US20120094972 Heterocyclic compounds and their uses
04/19/2012US20120094971 Compositions Including 6-Aminohexanoic Acid Derivatives As HDAC Inhibitors
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094969 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
04/19/2012US20120094966 Organic compounds
04/19/2012US20120094964 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
04/19/2012US20120094963 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
04/19/2012US20120094961 Tumor eradication by inositol-tripyrophosphate
04/19/2012US20120094958 Quinolines as inhibitors of farnesyl pyrophosphate synthase
04/19/2012US20120094956 Treatment of Cancer with Specific RXR Agonists
04/19/2012US20120094952 Polysialic Acid Derivatives, Methods of Production, and Uses in Enhancing Cancer Antigen Production and Targeting
04/19/2012US20120094949 Histone modification patterns for clinical diagnosis and prognosis of cancer
04/19/2012US20120094947 Method for the selective therapy of disease
04/19/2012US20120094946 Glycosylated chlorambucil analogs and uses thereof
04/19/2012US20120094945 Discovery of Selective Glucocorticoid Receptor Modulators by Multiplexed Reporter Screening
04/19/2012US20120094943 Alpha 7 nicotinic receptor selective ligands
04/19/2012US20120094941 Mangiferin-Berberine Salt, Manufacturing Method and Use Thereof
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094932 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120094928 Compounds for enzyme inhibition
04/19/2012US20120094927 Therapy for mll-rearranged leukemia
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 2211